What Researchers Did
Researchers hypothesized that hyperbaric oxygen treatment (HBO) could be a safe and inexpensive supplementary therapy for oral potentially malignant disorders (OPMDs) by acting at cellular and molecular levels.
What They Found
The authors hypothesized that hyperbaric oxygen treatment (HBO) could address the hypoxia in oral potentially malignant disorders (OPMDs) like oral lichen planus and oral leukoplakia. They proposed that HBO might work by decreasing lymphocyte proliferation, promoting fibroblast apoptosis, and modulating various molecular expressions such as decreasing HIF, ICAM-1, TNF-α, TGF-β, and IFN-γ, while increasing VEGF expression and angiogenesis.
What This Means for Canadian Patients
If proven effective, hyperbaric oxygen treatment (HBO) could offer Canadian patients with oral potentially malignant disorders (OPMDs) a new, potentially safe and inexpensive supplementary therapy. This could improve outcomes for conditions like oral lichen planus and oral leukoplakia, which currently lack optimal treatments.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation is that this paper presents a hypothesis rather than empirical findings from a clinical trial or observational study.